Arena Pharmaceuticals Inc buy phonebroker
Summary
This prediction ended on 09.11.10 with a price of €11.45. With a performance of -5.37%, the BUY prediction for Arena Pharmaceuticals Inc by phonebroker closed slightly in the red. phonebroker has 50% into this predictionArena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arena Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -1.816% | -2.419% | 12.070% | 14.356% |
| iShares Nasdaq 100 | 4.333% | 8.073% | 32.493% | 59.393% |
| iShares Nikkei 225® | 0.657% | 1.234% | 2.682% | 5.342% |
| iShares S&P 500 | 2.968% | 4.613% | 26.496% | 49.719% |
Comments by phonebroker for this prediction
In the thread Arena Pharmaceuticals Inc diskutieren
Hochstufung von Halten auf Outperform
Update 09.11.2010: Hochstufung auf Outperform mit Kursziel um 1,80 Euro
Update 27.10.2010: Der neuerliche Kursrückgang resultiert auf den negativen Bescheid der FDA zur Zulassung der Schlankheitspille Lorcaserin, was aber noch nicht das AUS bedeutet.
Die Empfehlung stufe ich herunter von Kaufen auf Halten mit Kursziel 1,30 EURO.
Mehr Infos unter: http://www.zacks.com/stock/news/42073/Rude+Shock+for+Arena+Pharma
Stopped prediction by phonebroker for Arena Pharmaceuticals Inc
Arena Pharmaceuticals Inc
13.08.10
07.09.10
07.09.10
